Fitbit Receives Regulatory Clearance in Both the United States and Europe for ECG App to Identify Atrial Fibrillation (AFib)

September 20,2024

Fitbit (NYSE:FIT) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking in the

FitBit Receives Regulatory Clearance for ECG App to Identify Atrial Fibrillation (AFib) - Health Matters

Fitbit Atrial Fibrillation Detection: Company Received FDA Approval for New Way to Measure Irregular Heartbeats

2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society

fitbit Irregular Rhythm Notifications Software-only Mobile Medical Application Instructions

Mobile Health for Arrhythmia Diagnosis and Management

2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart

Mobile Health for Arrhythmia Diagnosis and Management

PDF) Opportunistic atrial fibrillation screening and detection in “self-service health check-up stations”: a brief overview of current technology potential and possibilities

Fitbit Irregular Heart Rhythm Notifications work in these countries

Samsung's ECG monitoring app gets FDA approval in the US

Fitbit Receives Regulatory Clearance in Both the United States and Europe for ECG App to Identify Atrial Fibrillation (AFib)

Clinical Validation of 5 Direct-to-Consumer Wearable Smart Devices to Detect Atrial Fibrillation: BASEL Wearable Study

Wearable technology and the cardiovascular system: the future of patient assessment - The Lancet Digital Health

Mobile health solutions for atrial fibrillation detection and management: a systematic review

Fitbit Afib detection has 2 million users so far - 9to5Google